PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2008

PHARMANIAGA BERHAD

Financial Year End

31/12/2008
Quarter4
Quarterly report for the financial period ended31/12/2008
The figureshave been audited

Attachments

4Q2008.pdf
417 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2008

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/12/2008
31/12/2007
31/12/2008
31/12/2007
RM'000
RM'000
RM'000
RM'000
1Revenue
328,243
292,817
1,305,646
1,183,983
2Profit/(loss) before tax
24,496
23,572
90,599
77,898
3Profit/(loss) for the period
17,922
16,447
61,409
51,718
4Profit/(loss) attributable to ordinary equity holders of the parent
17,789
16,069
60,031
50,080
5Basic earnings/(loss) per share (sen)
16.63
15.02
56.12
46.82
6Proposed/Declared dividend per share (sen)
27.00
18.00
27.00
18.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.6300
3.2700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced27 Feb 2009  
CategoryFinancial Results
Reference NoPB-090226-36198